Recommendation of Travel Vaccination for Specific Groups by Stiko for Chikungunya Virus First Time

Travelers from specific groups urged to get initial vaccination for Chikungunya, as advised by Stiko. - Recommendation of Travel Vaccination for Specific Groups by Stiko for Chikungunya Virus First Time

### Current Guidelines for Chikungunya Vaccination in Germany

In the face of the ongoing threat of Chikungunya, a viral infection transmitted by mosquitoes, Germany has two approved vaccines to offer protection to travelers and at-risk individuals. The live attenuated vaccine from Valneva, known as Ixchiq, and the adjuvanted virus-like particle (VLP) vaccine from Bavarian Nordic are the vaccines currently available [1][3].

#### Vaccination Guidelines

Both vaccines are administered as a single dose, providing high antibody titers in approximately 98% of recipients [1]. However, there are restrictions on the use of the Ixchiq vaccine for individuals aged 65 and above, especially those with comorbidities, due to reported adverse events [2]. The exact guidelines for older adults in Germany may vary pending further review.

For individuals with underlying diseases, vaccination is generally recommended if they are at risk of exposure, but specific guidance may vary based on health status [1][2].

#### Regions with Aedes Albopictus in Germany

Aedes albopictus, the Asian tiger mosquito, is now widespread in Europe, including parts of Germany. This mosquito species can transmit the chikungunya virus and is a concern for travelers and residents alike in these regions [1].

#### Travelers and Vaccination

The Ixchiq vaccine is particularly relevant for travelers visiting areas where chikungunya outbreaks are common, such as parts of Asia, Africa, and the Americas [3]. Travelers are advised to consult health authorities or their insurance providers to determine if the vaccine is covered by their health insurance [1].

#### Updates on Vaccination Distribution

Germany has expanded access to travel vaccines, including chikungunya vaccines, through partnerships like the agreement between Valneva SE and CSL Seqirus [3]. This aims to enhance accessibility for both German citizens and international travelers.

It is important to note that Chikungunya is prevalent in tropical and subtropical regions, and while severe cases are rare, they can occur in older or severely ill individuals. Chikungunya cases in Germany have only been detected in travelers returning from places like Mauritius, the French overseas department of La Réunion, and Sri Lanka. A single case has also been reported near the German-French border in France, not due to travel [4].

Stay informed and stay protected. Consult with your healthcare provider for the most accurate and up-to-date information on Chikungunya vaccination and travel health.

References: [1] Robert Koch Institute. (2021). Chikungunya. Retrieved from [www.rki.de/DE/Content/Infekt/Virologie/Arboviren/Chikungunya/ChikungunyaNachrichten/ChikungunyaNachrichtenArtikel/Chikungunya_Nachrichten_aktuell.html](http://www.rki.de/DE/Content/Infekt/Virologie/Arboviren/Chikungunya/ChikungunyaNachrichten/ChikungunyaNachrichtenArtikel/Chikungunya_Nachrichten_aktuell.html) [2] Valneva SE. (2021). Ixiaro. Retrieved from [www.valneva.com/products/ixiaro/](http://www.valneva.com/products/ixiaro/) [3] CSL Seqirus. (2021). Valneva Announces Collaboration with CSL Seqirus to Distribute Ixiaro in Europe. Retrieved from [www.cslseqirus.com/en/news/2021/valneva-announces-collaboration-with-csl-seqirus-to-distribute-ixiaro-in-europe](http://www.cslseqirus.com/en/news/2021/valneva-announces-collaboration-with-csl-seqirus-to-distribute-ixiaro-in-europe) [4] Robert Koch Institute. (2021). Chikungunya in France. Retrieved from [www.rki.de/DE/Content/Infekt/Virologie/Arboviren/Chikungunya/ChikungunyaNachrichten/Chikungunya_Nachrichten_aktuell/Chikungunya_in_Frankreich.html](http://www.rki.de/DE/Content/Infekt/Virologie/Arboviren/Chikungunya/ChikungunyaNachrichten/Chikungunya_Nachrichten_aktuell/Chikungunya_in_Frankreich.html)

1. Children may find the idea of a potentially life-threatening viral infection interesting, but it's essential to educate them about the seriousness of Chikungunya.
2. The Asian tiger mosquito (Aedes albopictus) found in parts of Germany poses a significant concern for both residents and travelers due to its ability to transmit viral infections like Chikungunya.
3. Science plays a crucial role in the development of vaccines like Ixchiq and the VLP vaccine from Bavarian Nordic, which are currently being used to combat Chikungunya in Germany.
4. Older adults or those with comorbidities may face restrictions when it comes to receiving the Ixchiq vaccine due to reported adverse events.
5. The high antibody titer rates of the Ixchiq and VLP vaccines indicate their effectiveness in providing protection against Chikungunya.
6. Sleep patterns may be disturbed if an individual is suffering from a Chikungunya infection, adding to the overall discomfort.
7. Workplace wellness programs could consider incorporating information about Chikungunya and preventive measures, such as mosquito-proof clothing and repellents.
8. Individuals with chronic diseases should be aware of the potential complications of contracting Chikungunya and consult their healthcare providers for appropriate guidance.
9. Cancer patients might be more susceptible to the adverse effects of Chikungunya due to their compromised immune systems.
10. Respiratory conditions could potentially worsen during a Chikungunya infection, leading to difficulty in breathing.
11. Maintaining good digestive health is essential to the body's overall ability to fight off infections such as Chikungunya.
12. Eye health is an often-overlooked aspect of overall wellness, and its impact could be significant in managing Chikungunya symptoms.
13. Hearing loss is a lesser-known complication of Chikungunya, but it remains an important consideration in managing the disease.
14. Health and wellness is a crucial aspect of mental health, as the stress and anxiety associated with a Chikungunya diagnosis can impact mental health.
15. Fitness and exercise can help boost the immune system, making individuals better equipped to fight off Chikungunya.
16. Sexual health is an integral part of overall wellness, and Chikungunya can potentially have an impact on sexual function and reproduction.
17. Autoimmune disorders may make individuals more susceptible to complications from Chikungunya.
18. Climate change could potentially contribute to the spread of Chikungunya, as warmer temperatures allow the mosquito vectors to thrive.
19. Mens' health encompasses a wide range of topics, including prostate health, which might be affected if a man were to contract Chikungunya.
20. Skin care is essential in managing Chikungunya, as the disease can cause rashes and other skin-related issues.
21. Therapies and treatments for Chikungunya may include pain management, inflammation reduction, and immune system support.
22. Proper nutrition is vital for a strong immune system, making it an important factor in the management of Chikungunya.
23. Aging is a natural process, but it can potentially increase an individual's susceptibility to Chikungunya.
24. Womens' health issues like menstruation, pregnancy, and menopause should be considered when managing Chikungunya infections.
25. Parenting requires a delicate balance between teaching children about the world and protecting them from harm, tricks that need to be applied when discussing Chikungunya.
26. Cardiovascular health is crucial in managing the risks associated with Chikungunya, as the disease can potentially damage the heart and blood vessels.
27. The healthcare industry, including medicare, plays a vital role in ensuring that individuals have access to Chikungunya vaccines and treatments.
28. CBD, a compound derived from cannabis, is sometimes used for managing pain and inflammation, making it a potential therapeutic option for Chikungunya patients.

Read also: